Gilead Sciences (NASDAQ:GILD) Signs $1.2 billion Six-Month Joint Procurement Deal For Remdsivir With EU States
The European Union has signed a procurement deal with Gilead Sciences (NASDAQ:GILD) for its COVID-19 drug. The EU will pay
Read more
Gilead Sciences (NASDAQ:GILD)